HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells.

Abstract
Human melanoma cells growth arrest irreversibly, lose tumorigenic potential and terminally differentiate after treatment with a combination of fibroblast interferon (IFN-beta) and the protein kinase C activator mezerein (MEZ). Applying subtraction hybridization to this model differentiation system permitted cloning of melanoma differentiation associated gene-7, mda-7. Expression of mda-7 inversely correlates with melanoma development and progression, with elevated expression in normal melanocytes and nevi and increasingly reduced expression in radial growth phase, vertical growth phase and metastatic melanoma. When expressed by means of a replication incompetent adenovirus (Ad.mda-7) growth of melanoma, but not normal early passage or immortal human melanocytes, is dramatically suppressed and cells undergo programmed cell death (apoptosis). Infection of metastatic melanoma cells with Ad.mda-7 results in an increase in cells in the G(2)/M phase of the cell cycle and changes in the ratio of pro-apoptotic (BAX, BAK) to anti-apoptotic (BCL-2, BCL-XL) proteins. Ad.mda-7 infection results in a temporal increase in mda-7 mRNA and intracellular MDA-7 protein in most of the melanocyte/melanoma cell lines and secretion of MDA-7 protein is readily detected following Ad.mda-7 infection of both melanocytes and melanoma cells. The present studies document a differential response of melanocytes versus melanoma cells to ectopic expression of mda-7 and support future applications of mda-7 for the gene-based therapy of metastatic melanoma.
AuthorsIrina V Lebedeva, Zao-zhung Su, Yonmee Chang, Shinichi Kitada, John C Reed, Paul B Fisher
JournalOncogene (Oncogene) Vol. 21 Issue 5 Pg. 708-18 (Jan 24 2002) ISSN: 0950-9232 [Print] England
PMID11850799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Growth Substances
  • Interleukins
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • interleukin-24
  • RNA
Topics
  • Adenoviridae (genetics)
  • Apoptosis
  • Cell Cycle
  • Cell Division
  • Cells, Cultured
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins (genetics, physiology)
  • Genes, Tumor Suppressor
  • Genetic Therapy
  • Genetic Vectors
  • Growth Substances (analysis, genetics, physiology)
  • Humans
  • Interleukins
  • Kinetics
  • Melanocytes (metabolism)
  • Melanoma (metabolism, pathology, therapy)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • RNA (analysis)
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: